||
PD-L1在癌症免疫原性化疗中的新机制
https://www.ebiotrade.com/newsf/2024-11/20241108064831421.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=d4bd5166-9f5e-46c9-9620-9ccf62b1e23d
01. | Immune Checkpoint Inhibitors | 165 篇 | 100.000% |
02. | Immunotherapy | 165 篇 | 100.000% |
03. | Humans | 158 篇 | 95.758% |
04. | B7-H1 Antigen | 98 篇 | 59.394% |
05. | Animals | 76 篇 | 46.061% |
06. | Programmed Cell Death 1 Receptor | 55 篇 | 33.333% |
07. | Female | 53 篇 | 32.121% |
08. | Mice | 51 篇 | 30.909% |
09. | Neoplasms | 50 篇 | 30.303% |
10. | Cell Line, Tumor | 46 篇 | 27.879% |
常用聚类 分析报告导出
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-11-8 11:25
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社